Literature DB >> 3742327

Development of malignant hyperthermia obscured by cardiopulmonary bypass.

R G MacGillivray, H Jann, E Vanker, L Gemmell, A E Mahomedy.   

Abstract

An episode of malignant hyperthermia occurring in a two-year-old child undergoing cardiac surgery is reported. The coincidental usage of hypothermic cardiopulmonary bypass obscured the classical presenting signs and symptoms of the syndrome. Once the clinical diagnosis was confirmed, rapid reversal was achieved with the administration of dantrolene sodium.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3742327     DOI： 10.1007/bf03010981

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


  15 in total

1.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

2.  Pitfalls in interpreting serum creatine phosphokinase activity.

Authors:  M A Nevins; M Saran; M Bright; L J Lyon
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

Review 3.  Neuroleptic malignant syndrome.

Authors:  R Kurlan; R Hamill; I Shoulson
Journal:  Clin Neuropharmacol       Date:  1984       Impact factor: 1.592

Review 4.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 5.  Current concepts. The malignant hyperthermia syndrome.

Authors:  T E Nelson; E H Flewellen
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

6.  End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia.

Authors:  L Baudendistel; N Goudsouzian; C Cote'; M Strafford
Journal:  Anaesthesia       Date:  1984-10       Impact factor: 6.955

7.  Temperature and ventilation after hypothermic cardiopulmonary bypass.

Authors:  R N Sladen
Journal:  Anesth Analg       Date:  1985-08       Impact factor: 5.108

8.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

9.  Human malignant hyperthermia: awake episodes and correction by dantrolene.

Authors:  G A Gronert; R L Thompson; B M Onofrio
Journal:  Anesth Analg       Date:  1980-05       Impact factor: 5.108

Review 10.  Malignant hyperthermia.

Authors:  G A Gronert
Journal:  Anesthesiology       Date:  1980-11       Impact factor: 7.892
View more
  5 in total

1.  Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.

Authors:  G C Allen; C B Cattran
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

2.  Massive rhabdomyolysis following cardiopulmonary bypass.

Authors:  Young Sam Kim; Yong Han Yoon; Joung Taek Kim; Wan Ki Baek
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-04-10

3.  Rare postoperative delayed malignant hyperthermia after off-pump coronary bypass surgery and brief review of literature.

Authors:  Monish S Raut; Sibashankar Kar; Arun Maheshwari; Ganesh Shivnani; Arun Kumar; Elvin Daniel; Sandeep Joshi; Amit Motihar; Priyanka Gupta
Journal:  Ann Card Anaesth       Date:  2016 Apr-Jun

4.  Malignant Hyperthermia: Report of Two Cases with a Neglected Complication in Cardiac Surgery.

Authors:  Mahdi Neshati; Manizheh Azadeh; Parinaz Neshati; Tyrone Burnett; Ryan Saenz; Bahman Karbasi; Ghader Shahmohammadi; Eskandar Nourizadeh; Mohsen Rostamzadeh
Journal:  J Tehran Heart Cent       Date:  2017-10

5.  Successful management of hypothermic cardiopulmonary bypass in a malignant hyperthermia susceptible patient.

Authors:  Shvetank Agarwal; Kevin Graham; Simon Kigwana; Manuel Castresana
Journal:  Ann Card Anaesth       Date:  2020 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.